Alteration of Early-Phase Piperaquine Disposition by Concurrent Administration of Clarithromycin in Healthy Volunteers
dc.contributor.author | Ademisoye A.I. | |
dc.date.accessioned | 2025-06-05T13:11:55Z | |
dc.date.available | 2025-06-05T13:11:55Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Malaria and Helicobacter pylori infections are some of the most prevalent infectious diseases causing thousands of deaths worldwide. Concurrent infections can exacerbate co-morbidities or make worse the management of malaria. Drug-drug interactions arising from activities of CYP450 during concurrent management of the co-infections could worsen management challenges and therapeutic outcomes. Fifteen healthy volunteers were administered single oral dose of P-Alaxin© consisting piperaquine (960 mg) and dihydroartemisinin (240 mg). Following a five-month wash out period, clarithromycin (500 mg) was administered twice daily for five days. A single dose of P-Alaxin© was administered on the 3rd day. Blood samples were collected within 48 hours and analyzed for plasma levels of the administered drugs using RP-HPLC methods. The Tmax was 5.2±2.11 h vs 5.47±2.56 h and did not vary significantly p>0.05. However, Cmax and AUC0-48, of piperaquine when concurrently administered with clarithromycin increased significantly (179.41±56.35 ng/ml vs 478.99 ± 148.86 ng/ml; 37,644.56 ± 16.716.95 vs 104,098.47 ± 53.311.57 ng/ml*h respectively (p<0.05).quine during concurrent administration could be a pointer to major drug interactions that may manifest during full course of management of the concurrent infections. pharmacokinetic parameters in the early phase metabolism of piperaquine during concurrent administration cou | |
dc.identifier.uri | 10.23880/apct-16000250 | |
dc.identifier.uri | https://repository.run.edu.ng/handle/123456789/5263 | |
dc.language.iso | en | |
dc.publisher | Advances in Pharmacology and Clinical Trials | |
dc.relation.ispartofseries | 9; 4 | |
dc.title | Alteration of Early-Phase Piperaquine Disposition by Concurrent Administration of Clarithromycin in Healthy Volunteers | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- alteration-of-early-phase-piperaquine-disposition-by-concurrent-administration-of-clarithromycin-in-healthy-volunteers.pdf
- Size:
- 590.27 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: